ad-block

Advertising seems to be blocked by your browser.

The ads help us provide this software and web site to you for free.

Please support our project by allowing our site to show ads.



MEDIA - Compro Tech. - Conexant (unused device function) Computer Driver Updates



Device types / MEDIA / Compro Tech. / Conexant (unused device function)


link Conexant (unused device function)
Compro Tech.
MEDIA
5.0.0.8
8-24-2009
Windows 7 (6.1) 64 bit
Driver Popularity
 
link Conexant (unused device function)
Compro Tech.
MEDIA
5.0.0.8
8-24-2009
Windows 7 (6.1) 32 bit
Driver Popularity
 
link Conexant (unused device function)
Compro Tech.
MEDIA
5.0.0.7
6-2-2008
Windows XP (5.1) 32 bit
Driver Popularity
 
link Conexant (unused device function)
Compro Tech.
MEDIA
5.0.0.8
8-24-2009
Windows XP (5.1) 32 bit
Driver Popularity
 
link Compro VideoMate X series Audio Capture
Compro
MEDIA
4.2.4.1
3-22-2006
Windows XP (5.1) 32 bit
Driver Popularity
 
link DTV-DVB 3054 Analog Audio Capture
DTV-DVB
MEDIA
1.0.1.8
12-6-2005
Windows XP (5.1) 32 bit
Driver Popularity
 
link Conexant (unused device function)
Compro Tech.
MEDIA
5.0.0.7
6-2-2008
Windows Vista (6.0) 32 bit
Driver Popularity
 



Description extracted from Wikipedia:

Drugbox | Watchedfields = changed | verifiedrevid = 464214968 | image = Prochlorperazine.svg | width = 250 | tradename = Compazine, Stemetil, others | Drugs.com =| MedlinePlus = a682116 | DailyMedID = Prochlorperazine | pregnancy_AU = C | pregnancy_US = N | pregnancy_category = | legal_AU = S4 | legal_AU_comment = / S3 | legal_US = Rx-only | legal_UK = POM | legal_UK_comment = / P | routes_of_administration = By mouth, rectal, intramuscular (IM), intravenous (IV) | bioavailability = Unknown, but presumed substantial | protein_bound = 91-99% | metabolism = Mainly Liver (CYP2D6 and/or CYP3A4) | elimination_half-life = 4-8 hours, differs with the method of administration | excretion = Biliary, (colored) inactive metabolites in urine | IUPHAR_ligand = 7279 | CAS_number_Ref =| CAS_number = 58-38-8 | ATC_prefix = N05 | ATC_suffix = AB04 | PubChem = 4917 | DrugBank_Ref =| DrugBank = DB00433 | ChemSpiderID_Ref =| ChemSpiderID = 4748 | UNII_Ref =| UNII = YHP6YLT61T | KEGG_Ref =| KEGG = D00493 | ChEBI_Ref =| ChEBI = 8435 | ChEMBL_Ref =| ChEMBL = 728 | IUPAC_name = 2-chloro-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine | C=20 | H=24 | Cl=1 | N=3 | S=1 | SMILES = Clc2cc1N(c3c(Sc1cc2)cccc3)CCCN4CCN(C)CC4 | StdInChI_Ref =| StdInChI = 1S/C20H24ClN3S/c1-22-11-13-23(14-12-22)9-4-10-24-17-5-2-3-6-19(17)25-20-8-7-16(21)15-18(20)24/h2-3,5-8,15H,4,9-14H2,1H3 | StdInChIKey_Ref =| StdInChIKey = WIKYUJGCLQQFNW-UHFFFAOYSA-N Prochlorperazine , sold under the brand name Compazine among others, is a medication used to treat nausea, schizophrenia, migraines, and anxiety. It is a less preferred medication for anxiety. It may be taken by mouth, rectally, injection into a vein, or injection into a muscle. Common side effects include sleepiness, blurry vision, low blood pressure, and dizziness. Serious side effects may include movement disorders including tardive dyskinesia and neuroleptic malignant syndrome. Use in pregnancy and breastfeeding is generally not recommended. It is a typical antipsychotic which is believed to work by affecting levels of dopamine in the brain. Prochlorperazine was approved for medical use in the United States in 1956. It is available as a generic medication. In 2016, it was the 288th most commonly prescribed medication in the United States, with more than a million prescriptions.